Building foundations for the future: The First European bank for iPS

Ever since the discovery of induced pluripotent stem cells (iPS) by Shinya Yamanaka in 2006 there has been much optimism of it's potential for therapy, overcoming the ethical dilemmas surrounding embryonic stem cells. They also allow for study of disease specific by generation of iPS from subject with a genetic disease